Pharvaris
Christoph Cirillo is a highly experienced professional in the field of clinical operations, with a background in managing global clinical studies and regulatory affairs. Christoph has worked in various roles in different pharmaceutical companies, including director roles and clinical project management. Christoph also has experience in scientific advising and clinical research, with a strong educational background in molecular and functional biology. Their expertise spans across different European countries, showcasing their strong communication skills and regulatory knowledge.
This person is not in any teams
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.